134 results
Page 4 of 7
6-K
EX-99
zttx fd4mxlv2
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
6-K
EX-1
y29gni64xrdmd4y v851
28 May 19
Current report (foreign)
7:04am
6-K
EX-99
qd8xer2 82i5gu8ox
7 Feb 19
As Representative of the several Underwriters
12:00pm
6-K
EX-99
w1bjxip3
7 Feb 19
As Representative of the several Underwriters
12:00pm
424B5
3evwm7msl txbniqymdv
5 Feb 19
Prospectus supplement for primary offering
5:12pm
424B5
t7ezmvl44yy1v jfa
4 Feb 19
Prospectus supplement for primary offering
5:52pm
6-K
EX-10.3
qx8gpu
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
6-K
EX-10.2
j5m g63ft7seh
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am
F-3/A
cwx olso0xm0g5
16 Oct 15
Shelf registration (foreign) (amended)
12:00am
20-F/A
EX-4.39
mbighzd
22 Sep 15
Annual report (foreign) (amended)
12:00am
424B3
EX-1
5r2pj8ul
8 Jun 15
Prospectus supplement
12:00am